Narrow-band ultraiolet B monotherapy plus calcipotriol in the treatment of vulgaris psoriasis.

Trial Profile

Narrow-band ultraiolet B monotherapy plus calcipotriol in the treatment of vulgaris psoriasis.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2013

At a glance

  • Drugs Calcipotriol (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date 21 May 2012 added as reported by Chinese Clinical Trial Register.
    • 10 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top